Researchers have identified a promising new speech biomarker that could significantly enrich clinical trials by reducing sample size requirements and enhancing statistical outcomes. By using speech ...
News-Medical.Net on MSN
Promising new speech biomarker could enrich antipsychotic clinical trials
Researchers have identified a promising new speech biomarker that could significantly enrich clinical trials by reducing ...
FDA acknowledged that AURORA and BEACON provided sufficient evidence that bitopertin significantly lowers PPIX and that there is a strong ...
Guzmán, P. and Halpern, M. (2026) Effects of Treatment Delays on Colorectal Cancer Survival. Journal of Cancer Therapy, 17, ...
News-Medical.Net on MSN
Ozempic users continue treatment when weight loss works despite side effects
By Dr. Priyom Bose, Ph.D. An examination of user reviews finds that people continue off-label Ozempic when it delivers ...
University of Florida lab predicts patient cancer treatment outcomes through artificial intelligence
Dr. Raquel Dias discusses her lab’s use of artificial intelligence to predict patient treatment outcomes across life sciences, agricultural sciences, and human health.
A page may soon turn on how mental health professionals diagnose certain disorders.
FDA acknowledged that AURORA and BEACON provided sufficient evidence that bitopertin significantly lowers PPIX and that there is a strong mechanistic and biological plausibility supporting the use of ...
RFK Jr. has stated leucovorin will help "large numbers of children who suffer from autism." Many experts are skeptical about that.
Guggenheim Securities Emerging Outlook: Biotech Summit 2026 February 12, 2026 12:30 PM ESTCompany ParticipantsR.
Author Table of Contents Media Contact For general and media inquiries and to book our experts, please contact: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results